Paravertebral block with retro-psoas block vs. femoral block for postoperative analgesia in TKA .
L3 paravertebral block combined with retro-psoas compartment block versus femoral nerve block for postoperative analgesia in total knee arthroplasty: A randomized controlled trial.
Saudi J Anaesth. 2025 01-Sep:. 10.4103/sja.sja_128_25Zusammenfassung der Studie
82 patients were assessed for eligibility, of whom 66 patients scheduled for primary unilateral total knee arthroplasty (TKA) were randomized to receive either femoral nerve block (FNB) or L3 paravertebral block combined with retro-psoas compartment block (L3 PVB-RPCB). Two patients were lost to follow-up, resulting in 64 patients included in the final analysis (32 per group). All patients received standardized general anesthesia and postoperative patient-controlled analgesia with intravenous sufentanil. The primary outcome of interest was total sufentanil consumption in the first 24 hours postoperatively. Secondary outcomes included pain intensity at rest and during movement, sensory dermatomal coverage at 20 minutes, need for rescue analgesia, patient satisfaction, and the incidence of nausea, vomiting, pruritus, and posterior knee pain. Outcomes were assessed over the first 24 postoperative hours. Overall, the results of the study revealed that L3 PVB-RPCB significantly reduced postoperative opioid consumption and improved early pain control compared with femoral nerve block alone, without increasing opioid-related adverse effects.
Vollständigen ACE-Bericht freischalten
Sie haben Zugang zu 4 weiteren KOSTENLOSEN Artikeln in diesem Monat.
Klicken Sie unten, um diese ACE Reports freizuschalten und anzusehen
Jetzt freischalten
Kritische Beurteilungen der neuesten, hochwirksamen randomisierten kontrollierten Studien und systematischen Übersichten in der Orthopädie
Zugang zu OrthoEvidence-Podcast-Inhalten, einschließlich Kooperationen mit dem Journal of Bone and Joint Surgery, Interviews mit international anerkannten Chirurgen und Diskussionsrunden zu orthopädischen Neuigkeiten und Themen
Abonnement von The Pulse, einem zweimal wöchentlich erscheinenden evidenzbasierten Newsletter, der Ihnen helfen soll, bessere klinische Entscheidungen zu treffen
Exklusiver Zugang zu Originalartikeln, einschließlich eigener systematischer Übersichten, sowie zu Artikeln über Methoden der Gesundheitsforschung und aktuelle orthopädische Themen